CRINETICS PHARMACEUTICALS IN (CRNX)
US22663K1079 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -235.46M | -214.53M | -163.92M | -107.64M | -73.81M | |||
| Depreciation Amortization | 1.29M | 1.10M | 980.00K | 920.00K | 950.00K | |||
| Change In Working Capital | 11.43M | 8.04M | 18.61M | 1.10M | 380.00K | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 44.31M | 39.08M | 29.12M | 17.04M | 10.46M | |||
| OPERATING CASH FLOW | -178.44M | -166.31M | -115.21M | -88.59M | -62.03M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -6.00M | -4.69M | -1.66M | -440.00K | -190.00K | |||
| Other Investing Activity | -242.85M | -195.72M | -172.32M | -56.05M | 400.00K | |||
| INVESTING CASH FLOW | -248.86M | -200.41M | -173.98M | -56.48M | 220.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 782.04M | 388.94M | 121.96M | 252.68M | 114.57M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | 0.00 | |||
| FINANCING CASH FLOW | 782.04M | 388.94M | 121.96M | 252.68M | 114.57M | |||
| CHANGE IN CASH | 354.73M | 22.22M | -167.23M | 107.61M | 52.76M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -178.44M | -166.31M | -115.21M | -88.59M | -62.03M | |||
| Capital Expenditure | -6.00M | -4.69M | -1.66M | -440.00K | -190.00K | |||
| FREE CASH FLOW | -184.44M | -170.99M | -116.87M | -89.03M | -62.22M | |||
All data in USD